How AI and other new technologies present novel compliance and enforcement risks and opportunities to the pharmaceutical industry.
The DOJ noted in its press release that this resolution illustrates the government’s emphasis on combating healthcare fraud, particularly through the use of the FCA.
Julie DiMauro1 min read
The company overstated diagnostic claims to boost sales of its flagship product Sucraid.
Alexander Barzacanos1 min read
DOJ sends clear signal over security standards that go with federal funding.
Julie DiMauro3 min read